Integration of (iSBIRT) for Teen Drug Use Into a Pediatric Network

This study has been withdrawn prior to enrollment.
(The project was not funded)
Sponsor:
Information provided by (Responsible Party):
Children's Hospital Boston
ClinicalTrials.gov Identifier:
NCT01454206
First received: October 5, 2011
Last updated: January 2, 2013
Last verified: January 2013
  Purpose

The Goal of this project is to integrate a previously-tested internet-facilitated Screening, Brief Intervention, and Referral to Treatment (iSBIRT) system for adolescent substance use into a large network of primary care offices, the Pediatric Practices of Children's Hospital Boston (PPOC).


Condition Intervention Phase
Substance Use
Behavioral: iSBIRT
Phase 2
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Integration of Internet-facilitated Screening, Brief Intervention, Referral to Treatment (iSBIRT) for Teen Drug Use Into a Pediatric Network

Further study details as provided by Children's Hospital Boston:

Primary Outcome Measures:
  • Provider attitude toward iSBIRT [ Time Frame: 12 months post baseline ] [ Designated as safety issue: No ]
    We will evaluate providers' acceptance of and attitude toward integrating iSBIRT into their practices.


Secondary Outcome Measures:
  • Youth connectedness to provider [ Time Frame: Baseline ] [ Designated as safety issue: No ]
    We will measure adolescents' attitudes toward their providers' advice regarding the health effects of substance use given during the visit

  • iSBIRT sustainability [ Time Frame: 12 months post ] [ Designated as safety issue: No ]
    We will measure rates of continued use of iSBIRT by practices 12 months after iSBIRT recruitment and implementation ends

  • Change in rates of adolescent substance use [ Time Frame: 3 months post baseline ] [ Designated as safety issue: No ]
    We will measure the change in rates of adolescent substance use from baseline to 3 months post study visit.

  • Change in rates of adolescent substance use [ Time Frame: 6 months post baseline ] [ Designated as safety issue: No ]
    We will measure the change in rates of adolescent substance use from baseline to 6 months post study visit.

  • Change in rates of adolescent substance use [ Time Frame: 12 months post baseline ] [ Designated as safety issue: No ]
    We will measure the change in rates of adolescent substance use from baseline to 12 months post study visit.


Enrollment: 0
Study Start Date: July 2012
Estimated Study Completion Date: December 2016
Estimated Primary Completion Date: October 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Treatment as Usual
Experimental: iSBIRT
Participants will receive the internet-facilitated screening, brief intervention and referral to treatment (iSBIRT intervention)
Behavioral: iSBIRT
Participants will be screened for substance use, view information about the health effects of substance use on the computer, and receive advice from the primary care provider regarding the health effects of substance use. Those found to be at "high risk" will complete an internet-based program encouraging them to change their substance use.

  Eligibility

Ages Eligible for Study:   12 Years to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 12-18 year olds
  • Coming for non-emergent care
  • Access to a private computer
  • Have email address

Exclusion Criteria:

  • Not available for follow-up questionnaires
  • Unable to read or understand English at a 6th grade reading level
  • Medically or emotionally unstable on the day of the visit
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01454206

Locations
United States, Massachusetts
Children's Hospital Boston
Boston, Massachusetts, United States, 02115
Sponsors and Collaborators
Children's Hospital Boston
Investigators
Principal Investigator: John R Knight, MD Children's Hospital Boston
  More Information

Additional Information:
No publications provided

Responsible Party: Children's Hospital Boston
ClinicalTrials.gov Identifier: NCT01454206     History of Changes
Other Study ID Numbers: CeASAR app RFADA12008
Study First Received: October 5, 2011
Last Updated: January 2, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Children's Hospital Boston:
cannabis abuse
alcohol abuse
substance abuse

ClinicalTrials.gov processed this record on August 21, 2014